Carson Block’s Latest Short Bet Is Burned by Novartis M&A Deal
Carson Block’s Muddy Waters wager against a hedge-fund favorite, Chinook Therapeutics Inc., took a hit Monday after Novartis
2023-06-12 23:49
Novartis Agrees to Buy Chinook for Up to $3.5 Billion
Novartis AG agreed to buy Chinook Therapeutics Inc. for as much as $3.5 billion to add two promising
2023-06-12 13:50
Qatar’s Top Dealmakers Get Ready for a Spending Power Boost
Qatar is targeting more investment in new frontiers and sectors like technology and health care, as high demand
2023-06-12 12:18
Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug
Eisai Co.’s Alzheimer’s disease drug developed with Biogen Inc. gained support from advisers to US regulators, paving the
2023-06-12 09:28
Illumina CEO DeSouza Resigns After Facing Pressure From Icahn
Illumina Inc.’s board accepted the resignation of Chief Executive Officer Francis deSouza, effective Sunday, according to a statement.
2023-06-11 20:45
Astra Enters Into $2 Billion-Plus Pact With UK Biotech Quell
AstraZeneca Plc entered a collaboration with UK biotech Quell Therapeutics potentially worth more than $2 billion to develop
2023-06-09 15:24
Novartis’s Sandoz Sees Pipeline Adding $3 Billion Sales by 2028
Novartis AG’s generic-drug unit Sandoz could add $3 billion in sales over the next five years from its
2023-06-08 13:54
Zuckerberg Is Helping to Propel Chicago’s Biotech Ambitions
For about a year, Northwestern University professor Shana Kelley and a group of more than 20 Chicago scientists
2023-06-07 22:52
Drug Safety Fears Spur Pentagon Plan to Test Widely Used Medicines
US military officials are so concerned about the quality of generic drugs that the Department of Defense is
2023-06-07 21:00
Contaminated Drugs, Shredded Papers: US FDA Uncovers Failures in India Pharma Factories
US inspectors have in recent months uncovered wide-ranging lapses at factories run by some of India’s biggest pharmaceutical
2023-06-07 13:58
AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs
When Japanese pharmaceutical company Daiichi Sankyo Co. discovered a groundbreaking cancer treatment, it turned to bigger Western drugmaker
2023-06-07 05:28
Merck Sues US, Calling Move to Cut Drug Prices ‘Extortion’
Merck & Co. is suing the US over a law that will allow the government to negotiate prescription-drug
2023-06-07 01:45